Literature DB >> 7716390

Malaria parasites and chloroquine concentrations in Tanzanian schoolchildren.

U Hellgren1, O Ericsson, C M Kihamia, L Rombo.   

Abstract

Subtherapeutic doses of chloroquine (CQ) are considered to promote development of Plasmodium falciparum resistance but little is actually known about the drug levels in the population in endemic areas. We have therefore measured blood concentrations of CQ in Tanzanian schoolchildren and related these to parasite microscopy. A total of 163 children (median age 11 years) in a suburb outside Dar es Salaam were followed during four weeks. Thick and thin blood films were obtained once weekly. Parasites were counted in 200 visual fields. CQ and desethyl-chloroquine (DECQ) were determined with HPLC in 100 microliters of capillary blood. During the study P. falciparum trophozoites were detected in a mean of 78% of the children, P. falciparum gametocytes in 7.7% and P. malariae parasites in a mean of 13%. The cumulative prevalence of P. falciparum trophozoites and P. malariae parasites was 96% and 28% respectively. On day 0 and day 28, CQ was found in 78% and 80% of the children and DECQ in 21% and 31% of them. A total of 19% of all children had a verified CQ intake during the study and 35% had probably taken CQ. With a few exceptions (9% had CQ concentrations > 100 nmol/l) drug levels were not sufficient to affect parasites with a reduced CQ susceptibility but could possibly promote development of resistance by eradicating the most susceptibility part of the parasite population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7716390

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  8 in total

Review 1.  Multispecies Plasmodium infections of humans.

Authors:  F E McKenzie; W H Bossert
Journal:  J Parasitol       Date:  1999-02       Impact factor: 1.276

2.  Concentrations of chloroquine and malaria parasites in blood in Nigerian children.

Authors:  F P Mockenhaupt; J May; Y Bergqvist; O G Ademowo; P E Olumese; A G Falusi; L Grossterlinden; C G Meyer; U Bienzle
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 3.  Application of pharmacogenomics to malaria: a holistic approach for successful chemotherapy.

Authors:  Rajeev K Mehlotra; Cara N Henry-Halldin; Peter A Zimmerman
Journal:  Pharmacogenomics       Date:  2009-03       Impact factor: 2.533

4.  How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.

Authors:  Stephen E D Nsimba
Journal:  J Ethnobiol Ethnomed       Date:  2006-01-10       Impact factor: 2.733

5.  Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria.

Authors:  Arletta Añez; Manuel Moscoso; Cecilia Garnica; Carlos Ascaso
Journal:  Malar J       Date:  2016-07-19       Impact factor: 2.979

6.  Predictors of residual antimalarial drugs in the blood in community surveys in Tanzania.

Authors:  Joanna Gallay; Emilie Pothin; Dominic Mosha; Erick Lutahakana; Festo Mazuguni; Martin Zuakulu; Laurent Arthur Decosterd; Blaise Genton
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

7.  Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance.

Authors:  Eva Maria Hodel; Abdunoor Mulokozi Kabanywanyi; Aggrey Malila; Boris Zanolari; Thomas Mercier; Hans-Peter Beck; Thierry Buclin; Piero Olliaro; Laurent Arthur Decosterd; Blaise Genton
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

8.  Antimalarial drug use in general populations of tropical Africa.

Authors:  Florence Gardella; Serge Assi; Fabrice Simon; Hervé Bogreau; Teunis Eggelte; Fatou Ba; Vincent Foumane; Marie-Claire Henry; Pélagie Traore Kientega; Léonardo Basco; Jean-François Trape; Richard Lalou; Maryse Martelloni; Marc Desbordes; Meïli Baragatti; Sébastien Briolant; Lionel Almeras; Bruno Pradines; Thierry Fusai; Christophe Rogier
Journal:  Malar J       Date:  2008-07-08       Impact factor: 2.979

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.